Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and developed innovations in medicine for more than three decades, with the goal of creating better health outcomes for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead’s vision is to create a healthier world for all people: we seek and develop innovation in our fight against some of the world’s most devastating diseases. We recognize the importance of partnering with communities around the world to expand access, improve health equity and fulfill our mission as a corporate citizen. Gilead supports and collaborates with community organizations across the globe that advance global health progress and address stigma, discrimination and other barriers to wellbeing.
Since 1987, Gilead has commercialized more than 25 innovative medicines, helping to transform treatment for people living with diseases such as HIV, viral hepatitis, COVID-19, neglected tropical diseases and cryptococcal meningitis around the world.
Our focus goes beyond medicines. We know that our innovation will have the most impact on patients when we help to remove societal barriers to care: our goal is to eliminate diseases and deliver meaningful impact backed up by rigorous assessment.